PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 19219621)

Published in Hum Genet on February 15, 2009

Authors

Céline Gaucher1, Odile Walrant-Debray, Thy-Minh Nguyen, Laure Esterle, Michèle Garabédian, Frédéric Jehan

Author Affiliations

1: Inserm U561, Hôpital Saint-Vincent-de-Paul, 82 avenue Denfert-Rochereau, 75014, Paris, France. celine.gaucher@parisdescartes.fr

Articles citing this

Tooth dentin defects reflect genetic disorders affecting bone mineralization. Bone (2012) 1.07

Genetic diagnosis of X-linked dominant Hypophosphatemic Rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type. BMC Med Genet (2011) 0.94

MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia. PLoS One (2013) 0.91

Is high resolution melting analysis (HRMA) accurate for detection of human disease-associated mutations? A meta analysis. PLoS One (2011) 0.90

Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment. Pediatr Nephrol (2011) 0.89

Hypophosphatemia and growth. Pediatr Nephrol (2012) 0.88

Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin. Am J Pathol (2010) 0.86

Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets. Clin Endocrinol (Oxf) (2011) 0.82

Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia. Periodontol 2000 (2013) 0.82

Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets. Pediatr Nephrol (2010) 0.82

A novel de novo mutation within PHEX gene in a young girl with hypophosphatemic rickets and review of literature. Ann Pediatr Endocrinol Metab (2014) 0.81

Three novel mutations in the PHEX gene in Chinese subjects with hypophosphatemic rickets extends genotypic variability. Calcif Tissue Int (2011) 0.80

Kbus/Idr, a mutant mouse strain with skeletal abnormalities and hypophosphatemia: identification as an allele of 'Hyp'. J Biomed Sci (2011) 0.76

Genetic Testing Confirmed the Early Diagnosis of X-Linked Hypophosphatemic Rickets in a 7-Month-Old Infant. J Investig Med High Impact Case Rep (2015) 0.75

Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets. Int J Mol Med (2016) 0.75

Enamel and dentin mineralization in familial hypophosphatemic rickets: a micro-CT study. Dentomaxillofac Radiol (2015) 0.75

A de novo mosaic mutation of PHEX in a boy with hypophosphatemic rickets. J Hum Genet (2015) 0.75

Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications. Eur J Endocrinol (2015) 0.75

Whole Exome Sequencing Reveals Novel PHEX Splice Site Mutations in Patients with Hypophosphatemic Rickets. PLoS One (2015) 0.75

Articles cited by this

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet (2000) 7.41

A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet (1995) 4.61

MODBASE, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res (2004) 4.54

DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet (2006) 4.49

A common molecular basis for three inherited kidney stone diseases. Nature (1996) 4.26

SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet (2005) 2.42

Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet (2005) 2.21

A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature. Medicine (Baltimore) (1958) 2.17

Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet (1997) 1.64

A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc Natl Acad Sci U S A (2008) 1.56

Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J (1997) 1.38

Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets. Am J Hum Genet (1997) 1.37

Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon. J Mol Biol (2000) 1.36

Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers. J Bone Miner Res (2000) 1.30

The wrickkened pathways of FGF23, MEPE and PHEX. Crit Rev Oral Biol Med (2004) 1.28

Information for the Coordinates of Exons (ICE): a human splice sites database. Genomics (2004) 1.24

Mutational analysis of PHEX gene in X-linked hypophosphatemia. J Clin Endocrinol Metab (1998) 1.20

Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. Genome Res (1997) 1.19

A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res (2005) 1.10

Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts. J Bone Miner Res (2002) 1.08

Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues. Eur J Hum Genet (1999) 1.00

Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets. Bone (2008) 0.92

Bioinformatic analysis of the neprilysin (M13) family of peptidases reveals complex evolutionary and functional relationships. BMC Evol Biol (2008) 0.90

Identification of fifteen novel PHEX gene mutations in Finnish patients with hypophosphatemic rickets. Hum Mutat (2000) 0.88

M13 endopeptidases: New conserved motifs correlated with structure, and simultaneous phylogenetic occurrence of PHEX and the bony fish. Proteins (2002) 0.88

PHEX gene mutations and genotype-phenotype analysis of Korean patients with hypophosphatemic rickets. J Korean Med Sci (2007) 0.87

Structure and function of disease-causing missense mutations in the PHEX gene. J Clin Endocrinol Metab (2003) 0.86

Inherited forms of rickets and osteomalacia. Baillieres Clin Endocrinol Metab (1988) 0.86

Somatic and germline mosaicism for a mutation of the PHEX gene can lead to genetic transmission of X-linked hypophosphatemic rickets that mimics an autosomal dominant trait. J Clin Endocrinol Metab (2005) 0.85

X-linked hypophosphatemia in Polish patients. 1. Mutations in the PHEX gene. J Appl Genet (2000) 0.85

Disease-causing missense mutations in the PHEX gene interfere with membrane targeting of the recombinant protein. Hum Mol Genet (2001) 0.85

A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets. J Clin Endocrinol Metab (1998) 0.84

X-linked hypophosphatemia attributable to pseudoexons of the PHEX gene. J Clin Endocrinol Metab (2001) 0.81

Three novel PHEX gene mutations in Japanese patients with X-linked hypophosphatemic rickets. Pediatr Res (2000) 0.81

Articles by these authors

Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study. Am J Hum Genet (2005) 1.97

Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest (2005) 1.96

Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone (2009) 1.94

Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency. Joint Bone Spine (2003) 1.59

GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance. J Clin Endocrinol Metab (2002) 1.13

European cystic fibrosis bone mineralisation guidelines. J Cyst Fibros (2011) 1.12

Multiple regulatory regions control the complex expression pattern of the mouse Cdx2 homeobox gene. Gastroenterology (2008) 1.12

Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D. J Pediatr (2003) 0.98

Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3. J Bone Miner Res (2006) 0.97

Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein-DNA complex formation and are associated with height and vitamin D status in adolescent girls. Hum Mol Genet (2005) 0.96

Longitudinal changes in maternal serum 1,25-dihydroxyvitamin D and insulin like growth factor I levels in pregnant women who developed preeclampsia: comparison with normotensive pregnant women. J Steroid Biochem Mol Biol (2004) 0.94

Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection. Rheumatology (Oxford) (2012) 0.92

Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation. J Clin Endocrinol Metab (2003) 0.91

Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect (2014) 0.89

The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations. J Biol Chem (2003) 0.87

Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin. Am J Pathol (2010) 0.86

Adverse interaction of low-calcium diet and low 25(OH)D levels on lumbar spine mineralization in late-pubertal girls. J Bone Miner Res (2010) 0.86

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int (2008) 0.85

Dentin noncollagenous matrix proteins in familial hypophosphatemic rickets. Cells Tissues Organs (2008) 0.83

Decreased fractional urinary calcium excretion and serum 1,25-dihydroxyvitamin D and IGF-I levels in preeclampsia. J Steroid Biochem Mol Biol (2007) 0.82

Exons and functional regions of the human vitamin D receptor gene around and within the main 1a promoter are well conserved among mammals. J Steroid Biochem Mol Biol (2007) 0.82

The microenvironment controls CDX2 homeobox gene expression in colorectal cancer cells. Am J Pathol (2007) 0.81

Analysis of AP2S1, a calcium-sensing receptor regulator, in familial and sporadic isolated hypoparathyroidism. J Clin Endocrinol Metab (2014) 0.80

Vitamin D receptor genotype in hypophosphatemic rickets as a predictor of growth and response to treatment. J Clin Endocrinol Metab (2008) 0.79

A high-fat diet induces lower expression of retinoid receptors and their target genes GAP-43/neuromodulin and RC3/neurogranin in the rat brain. Br J Nutr (2010) 0.78

Growth, calcium status and vitamin D receptor (VDR) promoter genotype in European children with normal or low calcium intake. J Steroid Biochem Mol Biol (2010) 0.77

Update on vitamin D and its newer analogues. Kidney Int (2003) 0.75

Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH). Eur J Gastroenterol Hepatol (2017) 0.75

Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort). Eur J Gastroenterol Hepatol (2016) 0.75